School of Medicine

While the battle against SARS-CoV-2 rages on, Washington University researchers and clinicians are fighting a rearguard action against drug-resistant infections that years of overprescribing have turned deadly.

What is our secret?

Up to half of older adults may have sleep apnea, a condition in which breathing and sleep are briefly interrupted many times a night. A new study from the School of Medicine shows that this chronic tiredness can have serious implications for road safety.

WashU infectious diseases doctors and engineers have worked with the St. Louis Symphony Orchestra and other cultural institutions on how to safely reopen and continue performances following the COVID-19 pandemic global shutdown in 2020.

A new study led by Washington University School of Medicine and the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, shows that a standard milk-based therapy plus treatment with a specific strain of gut bacteria reduces gut inflammation and promotes weight gain in infants with severe acute malnutrition.

A new multicenter study that includes researchers at Washington University School of Medicine in St. Louis, the Centers for Disease Control and Prevention (CDC), and Vanderbilt University Medical Center shows that transplant recipients who receive three doses of COVID-19 mRNA vaccine have greater protection than that provided with two doses.

Mark A. Rutherford at the School of Medicine received a $3.5 million grant from the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health to study therapies for noise-induced hearing loss.

Scanning the brains of newborns, researchers at Washington University School of Medicine in St. Louis have found that maternal exposure to poverty and crime can influence the structure and function of young brains even before babies make their entrances into the world.

The Society for Research in Psychopathology has awarded its Joseph Zubin Lifetime Achievement Award to WashU’s Deanna Barch in recognition of her lifetime contributions to the understanding of the field.

Alex Holehouse at the School of Medicine, along with collaborators at Wageningen University and Research and the University of Toronto, received a three-year $1.1 million grant from Human Frontier Science Program to study disordered proteins.